RK
Rachna Khosla
SVP, Business Development

Rachna Khosla insider trades: Amgen (AMGN) stock sales

SVP, Business Development, Amgen Last trade Aug 13, 2026 36 Form 4 filings
$1.6M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
4
Open-market trades
since 2022
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Rachna reports to the SEC

Open-market buys and sales

4 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 13, 2026AMGN↓ Sell$1.3M
Nov 12, 2025AMGN↓ Sell$299K
Jun 5, 2025AMGN↓ Sell$435K
Nov 9, 2022AMGN↓ Sell$113K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other AMGN insiders

Open-market trades in the last 12 months

About Rachna Khosla's insider trades

Rachna Khosla is SVP, Business Development at Amgen (AMGN). Since Nov 9, 2022, Rachna has reported no open-market purchases and 4 sales worth $2.2M on SEC Form 4. In the last 12 months: 2 sales ($1.6M).

Their filings also include shares withheld for taxes (24 filings), grants and awards (11 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AMGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.